CA2070286C - Non oxidative ophthalmic compositions and methods for preserving and using same - Google Patents

Non oxidative ophthalmic compositions and methods for preserving and using same Download PDF

Info

Publication number
CA2070286C
CA2070286C CA002070286A CA2070286A CA2070286C CA 2070286 C CA2070286 C CA 2070286C CA 002070286 A CA002070286 A CA 002070286A CA 2070286 A CA2070286 A CA 2070286A CA 2070286 C CA2070286 C CA 2070286C
Authority
CA
Canada
Prior art keywords
quaternary ammonium
composition
ammonium polymer
contact lens
ophthalmically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002070286A
Other languages
French (fr)
Other versions
CA2070286A1 (en
Inventor
Michelle P. Wong
Anthony J. Dziabo, Jr.
Peter Gyulai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CA2070286A1 publication Critical patent/CA2070286A1/en
Application granted granted Critical
Publication of CA2070286C publication Critical patent/CA2070286C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/12Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143Quaternary ammonium compounds
    • A61L12/145Polymeric quaternary ammonium compounds

Abstract

Ophthalmic compositions, such as those used to care for contact lenses, methods of preserving such compositions, and methods for disinfecting contact lenses using such compositions are disclosed. The compositions may comprise an ophthalmically acceptable, liquid aqueous medium and, included therein, an effective preserving or disinfecting amount of certain oxygen-containing ionene polymers.

Description

r:~ ;'~ <\ n (.
ry ~ v U~~C' f~~~~s WO 91/09523 PGT/US90/07479 , NON OXIDATIVE OPHTHALMIC COMPOSITTONS ANn METHODS FOR PRESERVING AND USING SAM~r Background of the Invention This invention relates to ophthalmic compositions and methods for preserving and using such compositions. More particularly, the present invention relates to ophthalmic , .
_5 compositions, e.g. , useful in caring for contact lenses, which include one or~ more of certain ionene polymers as preservatives or disinfectants, and to methods for disinfecting and/or preserving using such compositions.
various compositions, e.g., solutions, are used in _10 association with contact lenses to ensure that the lenses may be safely, comfortably and conveniently worn. Contact lens care compositions, for example, disinfecting compositions, preserving compositions, cleaning compositions, wetting compositions, canditioning compositions and the like, often _15 utilize at least one disinfectant or preservative, depending on the type of composition, for disinfecting or preserving contact lenses after wear or preserving the lens care composition itself. A contact lens disinfecting composition generally has sufficient antimicrabial activity so that when 20 the composition is contacted with a lens to be disinfected, microorganisms associated with the lens are killed or otherwise removed and the contact lens is effectively disinfected within a reasonable time, e.g., in the range of about 0.1 hour to about'12 hours. A contact lens disinfecting 25 composition may be termed a microbio-cidal composition. In contrast, a contact lens preserving composition has sufficient antimicrobial activity, often less of such activity than is present in a contact lens disinfecting composition, so that when the composition is contacted with a contact lens _30 substantially no increase in the microorganism population on the lens or in the composition is obtained. A contact lens r. ;r WO 91/09523 ~ ~ ~ ~ ~ ~ pGT/US90/0747~o.;'y- , 2 , preserving composition may be termed a microbio-static ,, composition. Other contact lens care compositions are preserved to prevent any substantial increase in the ' population of contaminating microorganisms in the compositions _5 and, thereby, to extend their shelf life. Such preserved contact lens care compositions may be termed microbio-static compositions. Some preservatives used in lens preserving compositions or in preserved compositions may also be used as ,.
disinfecting agents in lens disinfecting compositions.
_10 ~ Various compounds are known for use as preserving agents in contacts lens preserving compositions and preserved contact lens care compositions. Examples include thimerosal, benzalkonium chloride and chlorhexidine. However, these preserving agents are known to exhibit ocular toxicity which y _15 may result in irritation or sensitivity to the eye. The , degree of ocular toxicity increases when these agents are , utilized as disinfecting agents. Further, a soft contact w lens, a rigid gas permeable contact lens (RGP) or a hard contact lens can absorb or adsorb these compounds. This ~, 20 causes the contact lens to retain the irritating compound and - r contributes to the eye irritation and sensitivity which may .
result.
Stark U.S. Patent No. 4,525,346 discloses a contact y lens disinfecting solution and preserved contact lens care _25 compositions containing 1-tris (2-hydroxyethyl) ammonium-2-butenyl-4-poly [1-dimethyl ammonium-2-butenyl]-w-tris (2-hydroxyethyl-) ammonium the salt of which has a pharmaceutically acceptable anion. The quaternary ammonium polymer disclosed in this Stark patent is capable of causing _30 irritation and sensitivity to some contact lens wearers.
Japanese Patent Publication 63131124 discloses a ' liquid composition for contact lens care including as an antimicrobial component a polymeric condensate of a diamine, such as N, N, N', N' - tetramethyl 1,2-diaminoethane, and a .. , : _' ; . :; n~ '.; y, .. '. ~ ..<t,. .... ~. - ' . ~.,y ,y ;'.. . . - , :.. ::
,:.

~~~~~~s .
dihalogen compound, such as 1,2-dichloroethane. Such polymeric condensates include no oxygen. Further, there is no suggestion that other polymeric condensates are useful as antimicrobial agents in the contact lens care context.
_5 Other conventional methods of contact lens chemical disinfection utilize one or more active disinfecting agents in an aqueous medium, for example a chlorhexidine/thimerosal .
solution or a relatively mild solution of hydrogen peroxide.
Some of these disinfecting solutions, such as those named above, are cytotoxic and are known to be adsorbed or absorbed onto or into a contact lens and cause the lens to elicit a cytotoxic response after disinfection. For example, contact lenses which have been soaked in a disinfecting hydrogen peroxide solution are to be treated to remove residual hydrogen peroxide, e.g., by soaking in a catalase solution, before they may be comfortably and safely worn again. If residual hydrogen peroxide remains on the lenses, then irritation or injury to the eye may result. A lens disinfecting system employing a substantially non-oxidative disinfectant composition is particularly useful since the risk of introducing active oxidizing agents into the eye is substantial~.y eliminated . ~ , Ellis et al U . S . Patent 4 ,168 , I12 discloses treating an sonically charged contact lens with a lens solution containing an oppositely charged ionic polymer to form a hydrophilic polyelectrolyte complex on the lens surface. This complex forms a hydrogel and acts as a cushion which provides comfort to the eye. Ionene polymers are among the many ionic polymers disclosed by Ellis et al. In addition, Ellis et al discloses that other additives, such as preservatives, e.g., benzalkonium chloride, ethylenediaminetetraacetic acid, mercurials and chlorobutanol, can be included in the lens treating solutions. Ellis et al does not distinguish between ionene polymers, nor is there any suggestion than any ionene y WO 91/09523 ~ ~ ~.~ ~ ~. ~ PCT/US90/0747 :.~~ .
.~,.
polymers are useful as preservatives or disinfectants in the 1 contact lens care context.
Stockel et al U.S. Patent 4,499,077 discloses oxidative contact lens disinfecting compositions including stabilized chlorine dioxide and a quaternary ammonium compound which is a copolymer of at least one mono-or di-tertiary amine and a dihalo organic compound. Stockel U.S.. Patent 4,654,208 discloses oxidative contact lens disinfecting compositions ' including one or more of the quaternary ammonium copolymers noted above in this paragraph plus a potentiating amount of . , an oxidizing agent. Neither of the Stockel et al patents disclose non-oxidation contact lens care compositions using such quaternary ammonium copolymers.
Thus, it is readily apparent that a continuing need exists for safe and efficacious compositions that can be used as contact lens disinfecting and preserving compositions and as preserved contact lens care compositions.
Summary of the Invention New disinfecting and preserving compositions and methods, particularly such compositions and methods directed v to contact lens care, have been discovered. The present compositions are substantially non-oxidative and include effective disinfectants and/or preservatives. Thus, for example, a contact lens can be effectively disinfected in a .
reasonable length of time. Also, contact lens care products can be effectively preserved against growth of contaminating microorganisms. Importantly, such disinfecting and preserving activities are achieved and the contact lenses disinfected, preserved or otherwise cared for using the present compositions can be safely and comfortably worn with little or no risk of eye irritation or sensitivity, e.g., from the .
presence of residual oxidizing agent.

~~~ g 6 PCT/US90/07479 Ey . WO 91 /09523 , In one broad aspect of the invention, a substantially non-oxidative composition useful for disinfecting, or preserving, a contact lens is provided. This composition includes an ophthalmically acceptable, preferably _5 sterile, medium, preferably a liquid aqueous medium. Included within this medium is an effective disinfecting, or preserving, amount of an ophthalmically acceptable quaternary .
ammonium polymer selected from ionene polymers containing an oxygen atom covalently bonded to two carbon atoms and mixtures _10 thereof. Methods of disinfecting, or preserving, a contact lens include contacting the lens to be disinfected, or preserved, with an appropriate composition, as described herein. Such ionene polymers are effective disinfectants and preservatives in the contact lens care context without the need for oxidizing agents. Contact lenses which are disinfected, preserved or otherwise treated using the present compositions can be safely and comfortably worn with little or no risk of eye irritation or sensitivity.
Preserved compositions, e.g:, contact lens care compositions, Which include an ophthalmically acceptable medium, preferably containing one or more components effective ~ .
to beneficially affect a contact lens and/or the wearing of a contact lens, are included within the scope of the present invention. Such preserved compositions are preferably _25 substantially non-oxidative, and include an effective preserving amount of an ophthalmically acceptable quaternary ~.
ammonium polymer, as described herein.
Detailed Description of the Invention The present invention is applicable to disinfecting y .
all types of lenses, e.g.; contact lenses, which are benefited by such disinfecting. Such lenses, e.g., conventional soft contact lenses, RGPs and hard contact lenses, may be made of any suitable material or combination of materials and may have any suitable configuration. The invention is also applicable WO 91/09523 - -~ ~. ~ ~ ~ PCT/US90/0747: ' to preserving compositions, such as contact lens care compositions, and other eye care products which are benefited by being preserved, w w One important feature of the vsubstantially non-_5 oxidative compositions of the presents invention is the inclusion of an effective, e.g., fo.r' disinfecting and/or preserving, amount of at least one ophthalmically acceptable .
quaternary ammonium polymer selected from the group consisting of ionene polymers containing an oxygen atom covalently bonded _10 to two carbon atoms, hereinafter referred to as "(C-O-C) ionene polymers",.and mixtures thereof. without wishing to limit the invention to any particular theory of operation, it is believed that the quaternary ammonium polymers useful in the present invention are sufficiently active to provide the 15 desired degree of disinfecting or preserving without causing substantial eye irritation or sensitivity.
v The presently useful quaternary ammonium polymers are distinguished from the quaternary ammonium polymer described in Stark U.S. Patent 4,525;346 and the polymeric 20 condensate described in Japanese Patent Publication 63131124. .
In the Stark patent and the Japanese Publication, the w quaternary ammonium polymer and the-polymeric condensate are not (C-O-C) ionene polymers. The presently useful quaternary a~nonium polymers provide the desired antimicrobial activity 25 without causing substantial eye irritation and sensitivity.
The presently useful quaternary ammonium polymers are preferably dispersible or soluble in the ophthalmically acceptable medium. Since contact lens disinfecting, preserving and other care compositions are most often 30 solutions,. the quaternary ammonium polymers are more preferably soluble~in the medium. The amount of quaternary ammonium polymer employed in the present compositions is that sufficient to effect the desired result. Care should be taken to avoid excessive amounts of quaternary ammonium polymer.

(.,.xa WO 91/09523 ~' Q,~ ~'~ PCT/US90/07479 v Not only are such materials quite expensive, but the use of large excesses of quaternary ammonium polymer may result in some degree of eye irritation and/or sensitivity. The presently useful quaternary ammonium polymers are preferably _5 present in an amount in the range of about 0.00001% to about 1%, more preferably about 0.0001% to about 0.5%, by weight per volume of ophthalmically acceptable medium. .
The presently useful quaternary ammonium polymers preferably have the following repeating unit A A
~+ +
0 - R - N - R4 -~ - R6 x t 1 ~ ~
R3 ~5 _15 wherein R1, R4 and R6 are each independently selected from alkylene radicals containing 1 to about 6 carbon a toms , R2 , R3 , RS and R7 are each independently selected from alkyl radicals containing 1 to about 6 carbon atoms, each A- is independently selected from ophthalmically acceptable anions, and x is the y number of repeating units in the polymer and is an integer in the' range of about 5 to about 30. A particularly useful quaternary ammonium polymer has the following repeating unit CH3 ~3 A I A
~. O - CH2 - CH2 + CH2 - CH2 N+ - CH2 - CH2 ~ x ~3 ~3 The number of repeating units per polymer molecule, represented by x, is more preferably about 8 to about 30, especially about 14.
Examples of.ophthalmically acceptable anions include chloride (C1-), bromide, iodide, bisulfate, phosphate, acid WO 91109523 PLTlUS90/07f79 phosphate, nitrate, acetate, maleate, fumarate, oxalate, lactate, tartrate, citrate, gluconate, saccharate, p-toluene sulfonate and the like. The preferred ophthalmically acceptable anion is C1-.
In one particularly useful embodiment, the quaternary ammonium polymer has a molecular weight in the range of about 500 to about 5000.
Methods for producing the presently useful quaternary ammonium polymers are described in Buckman et al U.S. Patent 4,250,269. A specific example of a quaternary ammonium polymer useful in the present invention is poly (oxyethylene (dimethyliminio) ethylene-(dimethyliminio) ethylene dichloride), such-as that sold by Buckman Laboratories, Inc. under the trademark WSCP.
The present compositions may include other, e.g., complementary and/or potentiating, antimicrobial agents.
Examples of such other antimicrobial agents include, but are not limited to, thimerosal, sorbic acid, 1.5-pentanedial, alkyl triethanolamines, boric acid, ophthalmically acceptable salts of any of the above, 3-chloroallyl-3, 5, 7, triaza-1-azonia adamantine chloride, phenylmercuric salts and mixtures thereof. Ophthalmically acceptable salts may include one or more ophthalmically acceptable anions, e.g., as noted above, or ophthalmically acceptable cations, in particular alkali and alkali metal cations. Materials which provide more than one beneficial or desired property to the present compositions may also be included. For example, certain combinations of quaternary ammonium compounds which possess both antimicrobial activity and wetting properties may be included. Examples of such combinations of quaternary ammonium compounds include, but are not limited to, balanced mixtures of N-alkyl dimethyl benzyl ammonium chlorides and N-alkyl dimethyl ethylbenzyl ammonium chlorides. Each of these agents/materials may be ~., WO 91/09523 ~'~ia~

included in the present compositions in an amount effective to provide the beneficial or desired property or properties.
The compositions of the present invention include an ophthalmically acceptable medium, preferably an _5 ophthalmically acceptable liquid aqueous medium. This medium often acts as a carrier, e.g., as a solvent, for the other components in the composition. A material is "ophthalmically .
acceptable" if the material can be placed into a mammalian eye without causing any substantial damage or harm to the eye.
_10 One particularly useful ophthalmically acceptable medium is water. Preferably, the medium, and in fact the entire composition, is sterile.
One or more additional components can be included in the present compositions based on the particular _15 . application for which the compositions are formulated. Thus, ~ .
the present compositions can be formulated as disinfecting compositions, cleaning compositions, wetting compositions, conditioning compositions, soaking compositions and the like.
Also, the present compositions can be~formulated to be useful _20 in performing two or more contact lens caring operations . For example, a disinfecting/cleaning composition, or a cleaning/conditioning composition or even an all purpose lens care composition can be formulated and such multi-functional compositions are included within the scope of the present _25 invention.
The additional component or components included in the present compositions are chosen to impart or provide at least one beneficial or desired property to the compositions.
Such additional components may be selected from components _30 which are conventionally used in one or more contact lens care compositions. Examples of such additional components include buffering agents, cleaning agents, wetting agents, nutrient agents, sequestering agents, viscosity builders, tonicity agents, contact lens conditioning agents, antioxidants, pH

WO 91 /09523 ~ ~ ~ ~ ~ ~ PCf/US90/0747 ~y;;
adjusters, and the like. These additional components are each included in the present compositions..in an amount effective to impart or provide the beneficial or'desired property to the compositions. For example, such additional components may be 5 included in the present compositions in amounts similar to the amounts of such components used in other, e.g., conventional, contact lens care products. - ' Useful buffering agents include, but not limited to, acetate buffers, citrate buffers, phosphate buffers and 10 borate buffers. Acids and bases may be used to adjust the pH
of the present compositions as needed.
Useful wetting agents include, but are not limited to, polyvinyl alcohol, poloxamers, polyvinyl pyrrollidone, .
hydroxypropyl methyl cellulose and mixtures thereof.
~ Useful sequestering agents include, but are not limited to, disodium ethylene diamine tetraacetate, alkali metal hexametaphosphate, citric acid, sodium citrate and mixtures thereof.
Useful tonicity adjusters include, but are not 20' , limited to, sodium chloride, potassium chloride, mannitol, w dextrose, glycerin, propylene glycol and mixtures thereof.
Useful viscosity builders include, but are not limited to, hydroxyethyl cellulose, hydroxy methyl cellulose, polyvinyl pyrrolidone, polyvinyl alcohol and mixtures thereof.
Useful antioxidants include, but are not limited to, sodium metabisulfite,.sodium thiosulfate, N-acetylcysteine, butylated hydroxyanisole, butylated hydroxytoluene and mixtures thereof.
In a particularly useful embodiment, the quaternary -3-0. ammonium polymer-containing composition further includes at least one enzyme effective to remove debris from a contact ' lens. Among the types of debris that form on a contact lens during normal use are protein-based debris, mucin-based debris, lipid-based debris and carbohydrate-based debris. One 'WO 91 /09523 PC'T/US90/07d79 or more types of debris may be present on a single contact lens.
The enzyme employed may be. selected from enzymes which are conventionally employed in the enzymatic cleaning of contact lenses. For example, many of the enzymes disclosed in Huth et al U . S . Patent RE 3 2 , 67 2 and Karageozian et al U . S .
Patent 3,910,296 are useful in the present invention.
Among the useful enzymes are those selected from proteolytic enzymes, lipases and mixtures thereof.
' Preferred proteolytic enzymes are those which are substantially free of sulfhydryl groups or. disulfide bonds.
Metallo-proteases, those enzymes which contain a d-tvalent metal ion such as calcium, magnesium or zinc bound to the protein, may also be used.
A more preferred group of proteolytic enzymes are the serine proteases , particularly those derived from Bacillus and Streptomyces bacteria and Asperigillus molds. within this grouping, the still more preferred enzymes are the derived alkaline proteases generically called subtilisin enzymes.
Reference is made to Deayl, L., Moser, P.W. and Wildi. B.S., "Proteases of the Genus Bacillus, II Alkaline Proteases", Biotechnology and Bioengineering, vol. XII, pp 213-249 (1970) and Keay, L. and Moser, P.w., "Differentiation of Alkaline Proteases form Bacillus Species" Biochemical and 3iophysical Research Comm., Vol 34, No. 5, pp 600-604, (1969).
The subtilisin enzymes are broken down onto two sub-classes, subtilisin A and subtilisin B. In the subtilisin A
grouping are enzymes derived from such species as _B . subtilis , H. licheniformis and B. pumilis. Organisms in this sub-class produce little or no neutral protease or amylase. The subtilisin B sub-class is made up of enzymes from such organisms as B. subtilis, B. subtilis var. amylosacchariticus, B. amyloliquefaciens and B. subtilis NRRL B3411. These WO 91/09523 2 O ~ O 'Z g .
PGT/US90/0747 ~ F=

organisms produce neutral proteases and amylases on a level about comparable to their alkaline protease production. One or more enzymes from the subtilisin A sub-class are particularly useful. .~~
In addition other preferred enzymes are, for example, pancreatin, trypsin, collaginase, keratinase, carboxylase, aminopeptidase, elastase, and aspergillo-peptidase A and B, pronase E ( from S. griseus ) and dispase (from B. polymyxa).
An effective amount of enzyme is to be used in the practice of this invention. Such amount will be that amount which effects removal in a reasonable time (for example overnight) of substantially all of at least one type of debris from a lens due to normal wear. This standard is stated with reference to contact lens wearers with a history of normal pattern of lens debris accretion, not the very small group who may at one time or another have a significantly increased rate of debris accretion such that cleaning is recommended every day, or every two or three days.
The amount of enzyme required to make an effective cleaner will depend on several factors, including the inherent activity of the enzyme, and the excipient it contains.
As a basic yardstick, the working solution should contain sufficient enzyme to provide about 0.001 to about 3 . Anson units of activity, preferably about 0.01 to about 1 Anson units, per single lens treatment. Higher or lower amounts may be used.
Enzyme activity is pH dependent . Thus , for any given enzyme, there is a particular pH range in which that enzyme will function best. The determination of such range can readily be done by known techniques.
The present compositions may be used in the care of a contact lens, e.g., to disinfect the lens, to preserve the w~ WO 91/09523 2~8 6 PGT/US90/07479 lens, to otherwise treat the lens and/or to make wearing the lens safe and comfortable. The present compositions, formulated appropriately, may be used in conventional contact lens care regimens by using the present compositions in place of prior conventional compositions. In many instances, these contact lens care regimens involve contacting the lens with the present composition in an amount, and at conditions, effective to obtain the beneficial or desired contact lens care result. For example, a contact~lens to be disinfected may be contacted with a disinfecting composition, e.g., aqueous solution, according to the present invention, preferably at a temperature in the range of about 0°C to about 100°C, more preferably in the range of about 10°C to about 60°
C and still more preferably in the range of about 15°C to about 30°C. Contacting at or about ambient temperature is very convenient and useful. The contacting preferably occurs at or about atmospheric.pressure. The contacting preferably occurs for a time to substantially disinfect the lens being treated. Such contacting times can be in the range of about 1 minute to about 12 hours or more.
After this contacting, the disinfected contact lens can be taken from the composition and placed directly in an eye, e.g.,. a human eye, for safe and comfortable wear.
Alternately, after being disinfected, the contact lens can be contacted with a second medium, e.g., a liquid aqueous medium such as a preserved isotonic saline solution, prior to being placed in the eye of the wearer of the disinfected contact lens.
- The contact lens care compositions disclosed herein are adaptable for use in most types of contact lens care equipment, such as ultrasonic cleaners and the like.
. The following examples are set out to illustrate, but not limit, the scope of this invention. ~.

WO 91 /09523 2 ~ ~ ~ 2 .8 .~ PCT/US90/0747 ~~~~ y .

A series of four (4) compositions were prepared by .
blending the constituents together. These compositions were as follows:
CONSTITUENT COMPOSITION (3) (4) ~~ WO 91/09523 Each of these compositions was tested for preservative efficacy and passed the USP preservative efficacy criteria.
These results demonstrate that certain quaternary 5 ammonium polymers, as described herein, at concentrations ranging from 60 ppm to 300 ppm by weight are effective antimicrobial preservatives far contact lens care products. _ Composition 3 is quite effective as a contact lens disinfecting solution in a standard contact lens care regimen, 10 with or without simultaneous or sequential enzymatic lens cleaning as part of the regimen.

Composition 3, described above, is used to disinfect a conventional soft contact lens as follows. 7.5 ml of the 15 composition is provided at room temperature. The contact lens to be disinfected is placed in the composition. Four hours after the contact lens is first introduced into the composition, it is removed from the composition and placed directly into the wearer's eye. It is found that after four hours, the contact lens is effectively disinfected. Also, the lens wearer experiences no discomfort or eye irritation form wearing the disinfected contact lens. Alternately, after the contacting for four hours noted above, the disinfected contact lens is rinsed with preserved or non-preserved sterile isotonic saline solution prior to placing the disinfected lens in the wearer's eye. The lens wearer experiences no discomfort or eye irritation from wearing the disinfected contact lens.

Example 5 is repeated except that about 50 ppm by weight of subtilisin A, based on the total weight of the Composition 3 used, is added at the same time the contact lens to be disinfected is added to the composition. Four hours after the contact lens is first introduced into the WO 91/09523 ~'~.e ' ~ ~ PCT/US90/0747 ~,;~..~f , composition, it is removed from the composition, rinsed with Composition 3, or with preserved or ,non-preserved sterile isotonic saline solution, and' placed directly into the wearer's eye. It is found that after four hours, the contact lens is effectively disinfected and cleaned of protein-based debris. Also, the lens wearer experiences no discomfort or eye irritation from wearing the disinfected and cleaned .
contact lens.
. While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims.

Claims (37)

WHAT IS CLAIMED IS:
1 . A method for disinfecting a contact lens comprising:
contacting a contact lens with a substantially non-oxidative composition including an effective disinfecting amount of an ophthalmically acceptable, quaternary ammonium polymer selected from the group consisting of ionene polymers containing an oxygen atom covalently bonded to two carbon atoms and mixtures thereof, at conditions to effectively disinfect said contact lens to be disinfected.
2. The method of claim 1 wherein said composition includes a liquid aqueous medium and an effective pH buffering amount of buffer.
3. The method of claim 2 wherein said quaternary ammonium polymer is present during said contacting in an amount in the range of about 0.00001%
to about 1% by weight per volume of said liquid aqueous medium.
4. The method of claim 2 wherein said contact lens after being disinfected is contacted with a second liquid aqueous medium prior to being placed in the eye of the wearer of said contact lens.
5. The method of claim 1 which further comprises contacting said contact lens in a liquid medium with at least one enzyme capable of removing debris from a contact lens in an amount effective to remove debris from said contact lens.
6. The method of claim 5 wherein said contact lens-quaternary ammonium polymer contacting and said contact lens-enzyme contacting occur at substantially the same time.
7. The method of claim 2 where said quaternary ammonium polymer has a molecular weight in the range of about 500 to about 5000 and said composition includes an effective pH buffering buffer.
8. The method of claim 1 wherein said quaternary ammonium polymer has a repeating unit wherein R1, R4 and R6 are each independently selected from the group consisting of alkylene radicals containing 1 to about 6 carbon atoms, R2, R3, R5 and R7 are each independently selected from alkyl radicals containing 1 to about 6 carbon atoms, each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is an integer in the range of about 5 to about 30, and said composition includes an effective pH buffering amount of buffer.
9. The method of claim 1 wherein said quaternary ammonium polymer has a repeating unit wherein each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is a integer in the range of about 8 to about 30.
10. The method of claim 9 wherein each A- is Cl- and x is about 14.
11. The method of claim 1 wherein said quaternary ammonium polymer is poly (oxyethylene (dimethyliminio) ethylene dimethyliminio) ethylene dichloride.
12. A method for preserving an ophthalmically acceptable medium comprising:
contacting a substantially non-oxidative ophthalmically acceptable medium useful in caring for a contact lens with an effective preserving amount of an ophthalmically acceptable, quaternary ammonium polymer selected for the group consisting of ionene polymers containing an oxygen atom covalently bonded to two carbon atoms and mixtures thereof, at conditions to effectively preserve said substantially non-oxidative, ophthalmically acceptable medium.
13. The method of claim 12 wherein said ophthalmically acceptable medium is sterile.
14. The method of claim 12 wherein said ophthalmically acceptable medium is a liquid aqueous medium and includes an effective pH buffering amount of buffer.
15. The method of claim 12 wherein said quaternary ammonium polymer is present during said contacting in an amount in the range of about 0.00001%
to about 1% by weight per volume of said ophthalmically acceptable medium.
16. The method of claim 14 where said quaternary ammonium polymer has a molecular weight in the range of about 500 to about 5000 and said buffer is a borate buffer.
17. The method of claim 14 wherein said quaternary ammonium polymer has a repeating unit wherein R1, R4 and R6 are each independently selected from the group consisting of alkylene radicals containing 1 to about 6 carbon atoms, R2, R3, R5 and R7 are each independently selected from alkyl radicals containing 1 to about 6 carbon atoms, each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is an integer in the range of about 5 to about 30 and said buffer is a borate buffer.
18. The method of claim 12 wherein said quaternary ammonium polymer has a repeating unit wherein each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is a integer in the range of about 8 to about 30.
19. The method of claim 18 wherein each A- is Cl- and x is about 14.
20. The method of claim 12 wherein said quaternary ammonium polymer is poly (oxyethylene (dimethyliminio) ethylene dimethyliminio) ethylene dichloride.
21. A composition useful for disinfecting a contact lens comprising an ophthalmically acceptable, liquid aqueous medium and, included therein, an effective contact lens disinfecting amount of an ophthalmically acceptable, quaternary ammonium polymer selected from the group consisting of ionene polymers containing an oxygen atom covalently bonded to two carbon atoms and mixtures thereof, and an effective pH
buffering amount of buffer, said composition being substantially non-oxidative.
22. The composition of claim 21 wherein said quaternary ammonium polymer is present in an amount in the range of about 0.00001% to about 1% by weight per volume of said ophthalmically acceptable liquid aqueous medium.
23. The composition of claim 21 which further comprises at least one enzyme capable of removing debris from a contact lens in an amount effective to remove debris from a debris laden contact lens.
24. The composition of claim 21 where said quaternary ammonium polymer has a molecular weight in the range of about 500 to about 5000, and said buffer is a borate buffer.
25. The composition of claim 21 wherein said polymer quaternary ammonium polymer has a repeating unit wherein R1, R4 and R6 are each independently selected from the group consisting of alkylene radicals containing 1 to about 6 carbon atoms, R2, R3, R5 and R7 are each independently selected from alkyl radicals containing 1 to about 6 carbon atoms, each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is an integer in the range of about 5 to about 30, and said buffer is a borate buffer.
26. The composition of claim 21 wherein said quaternary ammonium polymer has a repeating unit wherein each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is a integer in the range of about 8 to about 30.
27. The composition of claim 26 wherein each A- is Cl- and x is about 14.
28. The composition of claim 21 wherein said quaternary ammonium polymer is poly (oxyethylene (dimethyliminio) ethylene dimethyliminio) ethylene dichloride.
29. A preserved composition comprising an ophthalmically acceptable medium useful for caring for a contact lens and, included therein, an effective preserving amount of an ophthalmically acceptable, quaternary ammonium polymer selected from the group consisting of ionene polymers containing an oxygen atom covalently bonded to two carbon atoms and mixtures thereof, and an effective pH buffering amount of buffer, said composition being substantially non-oxidative.
30. The composition of claim 29 wherein said composition is sterile.
31. The composition of claim 29 wherein said ophthalmically acceptable medium is a liquid aqueous medium.
32. The composition of claim 29 wherein said quaternary ammonium polymer is present during said contacting in an amount in the range of about 0.00001%
to about 1% by weight per volume of said ophthalmically acceptable medium.
33. The composition of claim 31 wherein said quaternary ammonium polymer has a molecular weight in the range of about 500 to about 5000, and said buffer is a borate buffer.
34. The composition of claim 31 wherein said quaternary ammonium polymer has a repeating unit wherein R1, R4 and R6 are each independently selected from the group consisting of alkylene radicals containing 1 to about 6 carbon atoms, R2, R3, R5 and R7 are each independently selected from alkyl radicals containing 1 to about 6 carbon atoms, each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said quaternary ammonium polymer and is an integer in the range of about 8 to about 30, and said buffer is a borate buffer.
35. The composition of claim 29 wherein said quaternary ammonium polymer has a repeating unit wherein each A- is independently selected from the group consisting of ophthalmically acceptable anions, and x is the number of said repeating units in said oxygen-containing ionene polymer and is a integer in the range of about 8 to about 30, and said buffer is a borate buffer.
36. The composition of claim 35 wherein each A- is Cl- and x is about 14.
37. The composition of claim 29 wherein said quaternary ammonium polymer is poly (oxyethylene (dimethyliminio) ethylene dimethyliminio) ethylene dichloride.
CA002070286A 1990-01-05 1990-12-18 Non oxidative ophthalmic compositions and methods for preserving and using same Expired - Fee Related CA2070286C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/461,181 US5145643A (en) 1990-01-05 1990-01-05 Nonoxidative ophthalmic compositions and methods for preserving and using same
US461,181 1990-01-05
PCT/US1990/007479 WO1991009523A1 (en) 1990-01-05 1990-12-18 Non oxidative ophthalmic compositions and methods for preserving and using same

Publications (2)

Publication Number Publication Date
CA2070286A1 CA2070286A1 (en) 1992-04-06
CA2070286C true CA2070286C (en) 2000-08-29

Family

ID=23831522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070286A Expired - Fee Related CA2070286C (en) 1990-01-05 1990-12-18 Non oxidative ophthalmic compositions and methods for preserving and using same

Country Status (17)

Country Link
US (1) US5145643A (en)
EP (1) EP0509017B1 (en)
JP (1) JP2877513B2 (en)
AT (1) ATE135589T1 (en)
AU (1) AU636443B2 (en)
CA (1) CA2070286C (en)
DE (1) DE69026112T2 (en)
DK (1) DK0509017T3 (en)
ES (1) ES2085467T3 (en)
GR (1) GR3020062T3 (en)
HK (1) HK1005308A1 (en)
IE (1) IE74684B1 (en)
IL (1) IL96786A (en)
NZ (1) NZ236515A (en)
PT (1) PT96430A (en)
WO (1) WO1991009523A1 (en)
ZA (1) ZA9168B (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
JP3058656B2 (en) * 1990-06-18 2000-07-04 トーメー産業株式会社 Contact lens solution composition and method for cleaning or storing contact lenses using the same
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
US5352833A (en) * 1992-10-26 1994-10-04 Isp Investments Inc. Antibacterial polymeric quaternary ammonium compounds
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
TW243455B (en) * 1993-02-09 1995-03-21 Ciba Geigy
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
IL109705A (en) * 1993-06-17 1998-07-15 Allergan Inc Enzyme compositions and methods for contact lens cleaning
US5783532A (en) * 1993-06-17 1998-07-21 Allergan Enzyme compositions and methods for contact lens cleaning
JPH0776700A (en) * 1993-07-14 1995-03-20 Senju Pharmaceut Co Ltd Stabilization of agent for contact lens
US5536494A (en) * 1994-10-04 1996-07-16 Alcon Laboratories, Inc. Polyethylene oxide-containing quaternary ammunium polymers and pharmaceutical compositions containing an antimicrobial amount of same
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
WO1999033345A1 (en) * 1997-12-23 1999-07-08 Albright & Wilson Uk Limited Biocidal compositions and treatments
JP3605329B2 (en) * 1999-12-03 2004-12-22 日華化学株式会社 Ophthalmic solutions and contact lens solutions
ES2236180T3 (en) 2000-01-25 2005-07-16 Alcon Inc. ANTIALERGIC OPHTHALMIC COMPOSITIONS SUITABLE FOR USE WITH CONTACT LENSES.
JP3784609B2 (en) * 2000-03-31 2006-06-14 日華化学株式会社 Antibacterial agent for fiber and antibacterial fiber product
AUPQ679100A0 (en) * 2000-04-07 2000-05-11 Novapharm Research (Australia) Pty Ltd Process and composition for cleaning medical instruments
JP3542940B2 (en) * 2001-04-27 2004-07-14 日華化学株式会社 Disinfectant, antibacterial agent and antibacterial material
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions
US20090145086A1 (en) * 2007-12-11 2009-06-11 Reynolds Ger M Method for treating ophthalmic lenses
US20090145091A1 (en) * 2007-12-11 2009-06-11 Richard Connolly Method for treating ophthalmic lenses
SI2254549T2 (en) 2008-03-17 2019-08-30 Alcon Research, Ltd. Aqueous pharmaceutical compositions containing borate-polyol complexes
TWI544927B (en) 2008-03-17 2016-08-11 愛爾康研究有限公司 Pharmaceutical compositions having low concentration of surfactants for promoting bioavailability of therapeutic agents
US20090239954A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Phosphate buffered ophthalmic solutions displaying improved efficacy
US8093352B2 (en) * 2008-08-05 2012-01-10 Alcon Research, Ltd. Polyalkylene oxide polyquaternary ammonium biocides
TW201023912A (en) 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
WO2010101989A1 (en) 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
TW201038295A (en) 2009-04-17 2010-11-01 Alcon Res Ltd Aqueous ophthalmic compositions containing anionic therapeutic agents
TWI489997B (en) 2009-06-19 2015-07-01 Alcon Res Ltd Aqueous pharmaceutical compositions containing borate-polyol complexes
TWI478730B (en) 2009-12-03 2015-04-01 Alcon Res Ltd Ophthalmic emulsion
US20120269862A1 (en) 2011-04-22 2012-10-25 Chowhan Masood A Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
CN103491944A (en) 2011-04-22 2014-01-01 爱尔康研究有限公司 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
TWI544922B (en) 2011-05-19 2016-08-11 愛爾康研究有限公司 High concentration olopatadine ophthalmic composition
TW201336527A (en) 2012-02-10 2013-09-16 Alcon Res Ltd Aqueous pharmaceutical composition with enhanced stability
US10174006B2 (en) 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
TW201938141A (en) 2018-02-21 2019-10-01 瑞士商諾華公司 Lipid- based ophthalmic emulsion
AU2019297321B2 (en) 2018-07-02 2022-02-03 Ayuvis Research, Inc. Novel immunodulating small molecules
WO2020165840A1 (en) 2019-02-15 2020-08-20 Novartis Ag Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof
JP6994061B2 (en) 2019-02-15 2022-01-14 ノバルティス アーゲー Preparation of 4- (7-hydroxy-2-isopropyl-4-oxo-4H-quinazoline-3-yl) -benzonitrile
JP2023536938A (en) 2020-08-06 2023-08-30 ノバルティス アーゲー Crystal forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3771989A (en) * 1971-11-26 1973-11-13 Buckman Labor Inc Method of controlling the growth of algae
US3910296A (en) * 1973-04-20 1975-10-07 Allergan Pharma Method of removing proteinaceous deposits from contact lenses
US3912451A (en) * 1973-06-04 1975-10-14 Warner Lambert Co Method for removing hydrogen peroxide from soft contact lenses
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US4168112A (en) * 1978-01-05 1979-09-18 Polymer Technology Corporation Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same
JPS5513778A (en) * 1978-04-26 1980-01-30 Smith & Nephew Pharma Water soluble polymer*sterilization*and disinfectant colution
US4250269A (en) * 1979-11-26 1981-02-10 Buckman Laboratories, Inc. Water-soluble mixtures of quaternary ammonium polymers, nonionic and/or cationic vinyl-addition polymers, and nonionic and/or cationic surfactants
US4443429A (en) * 1980-11-28 1984-04-17 Bausch & Lomb Incorporated Contact lens disinfecting and preserving solution (polymeric)
US4499077A (en) * 1981-02-03 1985-02-12 Stockel Richard F Anti-microbial compositions and associated methods for preparing the same and for the disinfecting of various objects
US4532128A (en) * 1981-09-15 1985-07-30 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
US4482680A (en) * 1981-09-15 1984-11-13 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4615882A (en) * 1982-09-27 1986-10-07 Stockel Richard F Disinfectant solution for contact lens
US4654208A (en) * 1983-03-01 1987-03-31 Stockel Richard F Anti-microbial compositions comprising an aqueous solution of a germicidal polymeric nitrogen compound and a potentiating oxidizing agent
GB2139260B (en) * 1983-05-04 1986-09-03 Unilever Plc Bleaching and cleaning composition
US4568517A (en) * 1983-08-25 1986-02-04 Barnes-Hind, Inc. Disinfection of contact lenses
US4836986A (en) * 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
USRE32672E (en) * 1985-09-09 1988-05-24 Allergan, Inc. Method for simultaneously cleaning and disinfecting contact lenses using a mixture of peroxide and proteolytic enzyme
US4786436A (en) * 1986-01-31 1988-11-22 Bausch & Lomb Incorporated Wetting solutions for contact lenses
JP2550036B2 (en) * 1986-11-21 1996-10-30 株式会社メニコン Liquid composition for contact lens
US4783488A (en) * 1987-01-31 1988-11-08 Bausch & Lomb Incorporated Contact lens wetting solution

Also Published As

Publication number Publication date
AU7049791A (en) 1991-07-24
JP2877513B2 (en) 1999-03-31
JPH05502874A (en) 1993-05-20
NZ236515A (en) 1992-09-25
IL96786A0 (en) 1991-09-16
EP0509017A4 (en) 1993-02-24
US5145643A (en) 1992-09-08
ZA9168B (en) 1991-10-30
EP0509017A1 (en) 1992-10-21
EP0509017B1 (en) 1996-03-20
CA2070286A1 (en) 1992-04-06
GR3020062T3 (en) 1996-08-31
WO1991009523A1 (en) 1991-07-11
IL96786A (en) 1995-01-24
PT96430A (en) 1991-10-31
IE910030A1 (en) 1991-07-17
AU636443B2 (en) 1993-04-29
DE69026112D1 (en) 1996-04-25
DK0509017T3 (en) 1996-07-22
HK1005308A1 (en) 1998-12-31
DE69026112T2 (en) 1996-11-21
ES2085467T3 (en) 1996-06-01
ATE135589T1 (en) 1996-04-15
IE74684B1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
CA2070286C (en) Non oxidative ophthalmic compositions and methods for preserving and using same
EP0507816B1 (en) Ophthalmic compositions and methods for preserving and using same
US5451398A (en) Ophthalmic and disinfecting compositions and methods for preserving and using same
US9694099B2 (en) Ophthalmic and contact lens solutions using choline
AU674862B2 (en) Ophthalmic compositions and methods for preserving and using same
US5277901A (en) Ophthalmic compositions and methods for preserving and using same
WO1995027515A1 (en) Phospholipid preservation of hydrogen peroxide-containing compositions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed